Characteristics and Prognosis of Moderate or Severe Tricuspid Regurgitation

Recruiting Observational Study
Tricuspid Valve Disease
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 Months and older
Sex
Any
Study type
Observational
Participants needed
400 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The tricuspid valve : its evaluation is relatively difficult in echocardiography and the management of tricuspid valve diseases remains poorly codified.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age \>18 ans * inclusion criteria: moderate or severe tricuspid regurgitation * exclusion criteria: Refusal to participate/ prior surgery of the tricuspid valve
Contacts

Christophe TRIBOUILLOY, Pr

03 22 45 58 85

Tribouilloy.Christophe@chu-amiens.fr

CONTACT